• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Transcatheter aortic valve implantation results are not superimposable to surgery in patients with aortic stenosis at low surgical risk
CONCLUSIONS: TAVI and SVAR in the treatment of AS in the patients at low surgical risk are not superimposable. In particular, if 30-day and 1-year mortality, major bleeding and acute kidney injury were significantly lower for TAVI, the need of new PM implantation and paravalvular leak were significantly lower in SAVR. Consequently, we suggest the need of more trials to evaluate the effectiveness of TAVI as routine therapeutic procedure in the treatment of patients with low surgical risk AS.PMID:34622437 | DOI:10.5603/CJ.a2021.0114
Source: Cardiology Journal - October 8, 2021 Category: Cardiology Authors: Maria Cristina Acconcia Marco Alfonso Perrone Domenico Sergi Marco Di Luozzo Massimo Marchei Pasquale De Vico Antonio Sili Scavalli Giuseppe Pannarale Marcello Chiocchi Carlo Gaudio Francesco Romeo Quintilio Caretta Francesco Barill à Source Type: research

Comparison of dual antiplatelet therapy versus oral anticoagulation following transcatheter aortic valve replacement: A retrospective single-center registry analysis.
CONCLUSIONS: OAC after TAVR seems to reduce the risk of clinical valve thrombosis without a statistically significant increase in bleeding complications. PMID: 28497845 [PubMed - as supplied by publisher]
Source: Cardiology Journal - May 12, 2017 Category: Cardiology Authors: Holy EW, Kebernik J, Allali A, El-Mawardy M, Richardt G, Abdel-Wahab M Tags: Cardiol J Source Type: research